<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="irv12713-tbl-0004" xml:lang="en" orientation="portrait" position="float">
 <label>Table 4</label>
 <caption>
  <p>Virus sensitivity to NA inhibitors 
   <italic>in vitro</italic>
   <xref ref-type="fn" rid="irv12713-note-0008">a</xref>
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <thead valign="bottom">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" rowspan="2" valign="bottom" colspan="1">Virus</th>
    <th align="left" rowspan="2" valign="bottom" colspan="1">NA change</th>
    <th align="left" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">IC
     <sub>50</sub> values (nM) of NA inhibitors (fold differences
     <xref ref-type="fn" rid="irv12713-note-0009">b</xref>)
    </th>
   </tr>
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="bottom" rowspan="1" colspan="1">Oseltamivir carboxylate
     <xref ref-type="fn" rid="irv12713-note-0010">c</xref>
    </th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">Zanamivir</th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">Peramivir</th>
    <th align="left" valign="bottom" rowspan="1" colspan="1">Laninamivir
     <xref ref-type="fn" rid="irv12713-note-0011">d</xref>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">rPhuket3073/Yamagata
     <xref ref-type="fn" rid="irv12713-note-0012">e</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">wild‐type</td>
    <td align="char" char="±" rowspan="1" colspan="1">64.9 ± 11.7 (1.0)</td>
    <td align="char" char="±" rowspan="1" colspan="1">5.9 ± 1.1 (1.0)</td>
    <td align="char" char="±" rowspan="1" colspan="1">0.5 ± 0.1 (1.0)</td>
    <td align="char" char="±" rowspan="1" colspan="1">2.5 ± 0.1 (1.0)</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">rPhuket3073/Yamagata‐E117A
     <xref ref-type="fn" rid="irv12713-note-0013">f</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">E117A</td>
    <td align="char" char="±" rowspan="1" colspan="1">38 075.9 ± 7365.0 (586.6)</td>
    <td align="char" char="±" rowspan="1" colspan="1">164 197.3 ± 29 976.2 (27 830.0)</td>
    <td align="char" char="±" rowspan="1" colspan="1">14 959.5 ± 296.9 (29 919.0)</td>
    <td align="char" char="±" rowspan="1" colspan="1">54 022.7 ± 4659.7 (21 609.1)</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">B/Tokyo/UT‐AC032/2018</td>
    <td align="left" rowspan="1" colspan="1">G407S</td>
    <td align="char" char="±" rowspan="1" colspan="1">537.2 ± 215.7 (8.3)</td>
    <td align="char" char="±" rowspan="1" colspan="1">986.6 ± 507.9 (167.2)</td>
    <td align="char" char="±" rowspan="1" colspan="1">32.1 ± 12.9 (64.2)</td>
    <td align="char" char="±" rowspan="1" colspan="1">510.1 ± 244.4 (204.0)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot id="irv12713-ntgp-0005">
  <fn id="irv12713-note-0008">
   <label>a</label>
   <p>IC
    <sub>50</sub> values were determined by using an NA‐Fluor Influenza Neuraminidase Assay Kit. Average IC
    <sub>50</sub> values and standard deviations were calculated from three independent assays performed in duplicate.
   </p>
  </fn>
  <fn id="irv12713-note-0009">
   <label>b</label>
   <p>Compared with IC
    <sub>50</sub> values obtained with the sensitive control rPhuket3073/Yamagata.
   </p>
  </fn>
  <fn id="irv12713-note-0010">
   <label>c</label>
   <p>Oseltamivir carboxylate is the active form of oseltamivir.</p>
  </fn>
  <fn id="irv12713-note-0011">
   <label>d</label>
   <p>Laninamivir is the active form of laninamivir octanoate.</p>
  </fn>
  <fn id="irv12713-note-0012">
   <label>e</label>
   <p>A recombinant virus possessing the HA and NA genes from B/Phuket/3073/2013 and the remaining genes from B/Yamagata/1/73 virus.</p>
  </fn>
  <fn id="irv12713-note-0013">
   <label>f</label>
   <p>A recombinant Phuket3073/Yamagata virus with an E117A mutation in its NA.</p>
  </fn>
 </table-wrap-foot>
 <permissions>
  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
 </permissions>
</table-wrap>
